130 related articles for article (PubMed ID: 31462952)
1. Acute transient tachypnea following gadoxetate administration in a rhesus macaque during contrast-enhanced magnetic resonance imaging.
Aiosa NM; Laux J; Rojas O; Bennett RS; Logue J; Lee JH; Bollinger L; Byrum R; Claire MS; Feuerstein IM
Radiol Case Rep; 2019 Oct; 14(10):1272-1275. PubMed ID: 31462952
[TBL] [Abstract][Full Text] [Related]
2. Transient respiratory motion artifacts in multiple arterial phases on abdominal dynamic magnetic resonance imaging: a comparison using gadoxetate disodium and gadobutrol.
Tanabe M; Higashi M; Iida E; Onoda H; Ihara K; Ariyoshi S; Kameda F; Miyoshi K; Furukawa M; Okada M; Ito K
Jpn J Radiol; 2021 Feb; 39(2):178-185. PubMed ID: 32959222
[TBL] [Abstract][Full Text] [Related]
3. Effect of Gadoxetate Disodium on Arterial Phase Respiratory Waveforms Using a Quantitative Fast Fourier Transformation-Based Analysis.
Davenport MS; Malyarenko DI; Pang Y; Hussain HK; Chenevert TL
AJR Am J Roentgenol; 2017 Feb; 208(2):328-336. PubMed ID: 27929673
[TBL] [Abstract][Full Text] [Related]
4. Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium.
Bashir MR; Castelli P; Davenport MS; Larson D; Marin D; Hussain HK; Jaffe TA
Radiology; 2015 Jan; 274(1):141-8. PubMed ID: 25162310
[TBL] [Abstract][Full Text] [Related]
5. A low albumin level as a risk factor for transient severe motion artifact induced by gadoxetate disodium administration: A retrospective observational study with free-breathing dynamic MRI and an experimental study in rats.
Sugiura T; Okumura K; Sasaki M; Matsumoto J; Ogi T; Yoneda N; Kitao A; Kozaka K; Koda W; Kobayashi S; Gabata T
PLoS One; 2022; 17(3):e0265588. PubMed ID: 35303023
[TBL] [Abstract][Full Text] [Related]
6. Transient Severe Respiratory Motion Artifacts After Application of Gadoxetate Disodium: What We Currently Know.
Well L; Weinrich JM; Adam G; Bannas P
Rofo; 2018 Jan; 190(1):20-30. PubMed ID: 29156475
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of incidence of acute transient dyspnea and related artifacts after administration of gadoxetate disodium: a prospective observational study.
Grazioli L; Faletti R; Frittoli B; Battisti G; Ambrosini R; Romanini L; Gatti M; Fonio P
Radiol Med; 2018 Dec; 123(12):910-917. PubMed ID: 30084108
[TBL] [Abstract][Full Text] [Related]
8. Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality.
Davenport MS; Viglianti BL; Al-Hawary MM; Caoili EM; Kaza RK; Liu PS; Maturen KE; Chenevert TL; Hussain HK
Radiology; 2013 Feb; 266(2):452-61. PubMed ID: 23192781
[TBL] [Abstract][Full Text] [Related]
9. Respiratory motion artefacts in dynamic liver MRI: a comparison using gadoxetate disodium and gadobutrol.
Luetkens JA; Kupczyk PA; Doerner J; Fimmers R; Willinek WA; Schild HH; Kukuk GM
Eur Radiol; 2015 Nov; 25(11):3207-13. PubMed ID: 25903709
[TBL] [Abstract][Full Text] [Related]
10. Transient Severe Motion Artifact Related to Gadoxetate Disodium-Enhanced Liver MRI: Frequency and Risk Evaluation at a German Institution.
Well L; Rausch VH; Adam G; Henes FO; Bannas P
Rofo; 2017 Jul; 189(7):651-660. PubMed ID: 28445909
[No Abstract] [Full Text] [Related]
11. Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine.
Davenport MS; Caoili EM; Kaza RK; Hussain HK
Radiology; 2014 Jul; 272(1):123-31. PubMed ID: 24617733
[TBL] [Abstract][Full Text] [Related]
12. Rate of gadoxetate disodium (Eovist®) induced transient respiratory motion in children and young adults.
Lanier H; Wallace A; Khanna G
Abdom Radiol (NY); 2020 Jan; 45(1):101-106. PubMed ID: 31701191
[TBL] [Abstract][Full Text] [Related]
13. Comparison of transient severe motion in gadoxetate disodium and gadopentetate dimeglumine-enhanced MRI: effect of modified breath-holding method.
Song JS; Choi EJ; Park EH; Lee JH
Eur Radiol; 2018 Mar; 28(3):1132-1139. PubMed ID: 28986630
[TBL] [Abstract][Full Text] [Related]
14. Transient respiratory motion artifact during arterial phase MRI with gadoxetate disodium: risk factor analyses.
Kim SY; Park SH; Wu EH; Wang ZJ; Hope TA; Chang WC; Yeh BM
AJR Am J Roentgenol; 2015 Jun; 204(6):1220-7. PubMed ID: 26001231
[TBL] [Abstract][Full Text] [Related]
15. Gadoxetate disodium-induced tachypnoea and the effect of dilution method: a proof-of-concept study in mice.
Akai H; Yasaka K; Nojima M; Kunimatsu A; Inoue Y; Abe O; Ohtomo K; Kiryu S
Eur Radiol; 2018 Feb; 28(2):692-697. PubMed ID: 28894937
[TBL] [Abstract][Full Text] [Related]
16. Respiratory-motion artefacts in liver MRI following injection of gadoxetate disodium and gadobenate dimeglumine: an intra-individual comparative study in cirrhotic patients.
Furlan A; Close ON; Borhani AA; Wu YH; Heller MT
Clin Radiol; 2017 Jan; 72(1):93.e1-93.e6. PubMed ID: 27633725
[TBL] [Abstract][Full Text] [Related]
17. Transient severe motion in the arterial phase during gadoxetate disodium-enhanced MR imaging: evaluation of patients with multiple MR examinations.
Im WH; Song JS; Park EH; Kwak HS
Abdom Radiol (NY); 2017 Oct; 42(10):2393-2401. PubMed ID: 28396919
[TBL] [Abstract][Full Text] [Related]
18. Respiratory motion in children and young adults undergoing liver magnetic resonance imaging with intravenous gadoxetate disodium contrast material.
Gilligan LA; Trout AT; Anton CG; Schapiro AH; Towbin AJ; Dillman JR
Pediatr Radiol; 2019 Aug; 49(9):1171-1176. PubMed ID: 31203405
[TBL] [Abstract][Full Text] [Related]
19. Gadoxetate disodium-related event during image acquisition: a prospective multi-institutional study for better MR practice.
Kromrey ML; Hori M; Goshima S; Kozaka K; Hyodo T; Nakamura Y; Nishie A; Tamada T; Shimizu T; Kanki A; Motosugi U
Eur Radiol; 2020 Jan; 30(1):281-290. PubMed ID: 31338655
[TBL] [Abstract][Full Text] [Related]
20. Respiratory anomalies associated with gadoxetate disodium and gadoterate meglumine: compressed sensing MRI revealing physiologic phenomena during the entire injection cycle.
Glessgen CG; Breit HC; Block TK; Merkle EM; Heye T; Boll DT
Eur Radiol; 2022 Jan; 32(1):346-354. PubMed ID: 34324024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
